Press Release: Amiko : Amiko receives CE mark for use of the Respiro Platform with Teva's Spiromax®, Chiesi's Nexthaler® and GlaxoSmithKline's Ellipta® inhalers

The Respiro platform can now be used with drugs delivered via Spiromax, Nexthaler and Ellipta(PRWeb February 05, 2018)Read the full story at http://www.prweb.com/releases/2018/02/prweb15164006.htm